RUNX1 and leukemia: As mentioned earlier, expression of RUNX1/ETO in HSPCs blocks differentiation and enhances self-renewal capacity but leukemia develops as a result of concurrent mutations in signaling pathways and tyrosine kinases (class 1 mutations) that affect cell proliferation.